Built for pharmaceutical commercial teams

Pharma lead generation where every HCP outreach carries the MLR approval, the consent record, and the audit log the compliance team can pull in minutes.

Pharmaceutical marketing is not a regular B2B motion. Every asset passes medical, legal, and regulatory review, every outreach needs a consent record under state and federal rules, and every touch must survive an FDA Office of Prescription Drug Promotion inquiry years later. Most marketing platforms were designed for SaaS and bolt a compliance mode on top. Strkr was built for regulated motions from the record upward.

What this audience is actually dealing with

The pains that bring buyers here.

Commercial teams at pharma companies, from clinical-stage biotech with a first launch to top-20 pharma with a mature portfolio, land on the same set of problems when they go shopping for a marketing platform. The vendor demos look great until you ask about HCP consent capture, PhRMA Code adherence, Sunshine Act transfer-of-value reporting, 2253 submission support, state-level licensing variance (New Jersey, Massachusetts, Minnesota, Nevada, Vermont, DC each have specific HCP-interaction rules), and whether an MLR-rejected asset can actually be prevented from going out. Six specific pain points come up on nearly every pharma commercial call.

MLR workflow lives in email

The medical review happens in a mailbox and nobody can audit it.

The classic pharma MLR flow is: the brand team drafts a piece, emails it to medical, legal, and regulatory, each reviewer responds with tracked changes, the brand team consolidates, the asset ships. Three years later the OPDP writes to ask about the review history of a piece and the mailbox is a tangle nobody can reconstruct. Strkr runs MLR inside Projects with routed approvals, line-level comments, locked versions, and a hard gate that stops an unapproved piece from being attached to a campaign send.

HCP consent capture is thin

Marketo and Pardot were not designed for HCP opt-in nuance.

HCP consent in the US is not a single opt-in box. It carries license-state nuance, specialty filters for off-label vs on-label discussion, and renewal windows that differ by channel. The marketing platforms built for SaaS treat consent as a bool and the compliance team ends up building parallel spreadsheets. Strkr contact records carry a structured consent model with license state, specialty, channel, scope, grant date, source, and expiry, exposed in both the UI and the API so the audit answer takes seconds.

Sunshine Act transfer-of-value

Every dinner, every sample, every speaker fee becomes a reporting line.

The Physician Payments Sunshine Act requires annual reporting of transfers of value to covered recipients. Many commercial teams run Sunshine reporting as a Q1 fire drill, pulling data from four systems and reconciling it against a CMS template. Strkr tracks transfers of value as a first-class object on the HCP record (meal, honorarium, sample, travel, education) with the CMS Open Payments fields built in, so the annual filing is a report run, not a six-week project.

Rep triggers and compliance guardrails

Field reps need prompts that respect the state rules.

A field rep in Vermont has interaction rules that differ from a rep in Texas. A rep calling on a prescriber in Minnesota faces a different gift ceiling than a rep calling in Florida. Giving reps a generic "visit cadence reminder" workflow with no state logic leads to compliance violations that take years to surface in audits. Strkr Flow conditions on license state, specialty, and the local-rules table so the rep gets guidance that matches the specific HCP in context.

Analytics without the HIPAA risk

Prescriber-level analytics meet IQVIA data and nobody wants a breach.

Commercial analytics at pharma companies mixes CRM data, prescription data from IQVIA or Symphony, call plan data, and sometimes real-world evidence. The data environment carries HIPAA exposure if PHI leaks in, and most SaaS marketing platforms do not sign BAAs. Strkr signs BAAs, runs the analytics layer under row-level security tied to user territory, and keeps HCP identifiers tokenized where the brand team does not need to see them directly.

Launch readiness vs promo-only use

A pre-launch team needs the platform standing up before the DDMAC letter.

A clinical-stage biotech 12 months from a label expects to light up commercial infrastructure in a sprint. Enterprise marketing platforms built for mature portfolios take 6 to 9 months to deploy, which is a budget drag at the pre-launch stage when every month matters. Strkr can be deployed to pharma readiness in 3 to 6 weeks because the regulated primitives are built in rather than configured per customer.

What a pharma-ready marketing platform must do

The capability list a brand team can actually audit against.

Pharma commercial teams have a capability shortlist that generic marketing platforms miss. The cards below are the capabilities that come up on every pre-launch and in-market team call, in the order they tend to be asked about.

MLR routing

Medical, legal, regulatory review inside the asset record.

Every promotional piece routes through the three reviewers with line-level comments, required-approval gates, and locked final versions. The approval history travels with the asset for its lifecycle. An unapproved piece cannot be attached to a campaign send because the system enforces the gate at the campaign layer.

HCP consent model

Structured opt-in per channel per specialty.

Consent is captured per HCP, per channel, per scope (on-label discussion, off-label discussion, speaker invitation, dinner invite), with grant date, source, and expiry. Renewal workflows prompt the HCP before expiry. The consent record is queryable through the API for integration with other systems the compliance team runs.

Sunshine Act fields

Transfer-of-value capture with CMS Open Payments fields built in.

The HCP record carries structured transfer-of-value fields that match the CMS Open Payments schema: date, amount, nature of payment, form of payment, product indication, physician NPI, physician license state. The annual CMS filing is a report run against this structured data.

State-rule logic

Flow conditions on license state and specialty.

The Flow canvas can condition any step on the HCP license state, specialty, consent scope, and gift ceiling. A rep triggering a sample-delivery flow for a Minnesota prescriber gets the Minnesota logic. A rep triggering the same flow for a Texas prescriber gets Texas logic. The branching is explicit and auditable.

Sample management

PDMA sample tracking with signature capture.

Prescription Drug Marketing Act compliance requires sample distribution tracking with signature capture. Strkr tracks samples per HCP with lot number, expiration, quantity, and signature image, stored under the HCP record. Monthly reconciliation reports pull cleanly for internal audit review.

Call plan + territory alignment

Territory logic that respects the IQVIA data refresh.

Territory alignments shift twice a year on most pharma commercial calendars. Strkr supports territory versioning, HCP reassignment with history, and a holdout mechanism so the rep in the previous alignment keeps visibility to the deals they were working on. The IQVIA data refresh triggers a reconciliation flow instead of a manual data load.

Speaker bureau management

Speaker fee tracking, cap enforcement, aggregate reporting.

Speaker programs carry fee caps per calendar year under internal compliance policy and PhRMA Code guidance. Strkr tracks speaker events as Projects, with speaker fee totals rolled up per speaker per year, cap enforcement at the booking stage, and the aggregate going straight into the Sunshine Act dataset.

Audit log depth

Every field change retained for 7 years.

The pharma retention clock on commercial records runs 7 years post-use under most internal policies, longer in certain jurisdictions. Strkr retains full field-level audit history inside that window, with user, timestamp, before, after, and reason-code when captured. An OPDP inquiry answer takes a filter and a report, not a six-week reconstruction.

BAA and HIPAA posture

BAA signed for every tenant that touches PHI.

Strkr signs a Business Associate Agreement with every tenant that handles protected health information, which in pharma commercial often means patient-support programs and copay cards. HIPAA controls apply to the full tenant: encryption in transit and at rest, access logs, breach notification, and training materials for the admins who manage the tenant.

How Strkr runs the pharma commercial motion

What a day looks like for brand, field, and medical.

A pharma commercial organization has three audiences inside the platform. Brand teams who plan and run the campaigns, field reps who carry the message to prescribers, medical teams who review and respond to scientific inquiries. The cards below are how each cohort uses Strkr on a typical week.

Brand manager morning

Campaign dashboard with MLR status per asset.

The brand manager opens the campaign dashboard. Three assets are in MLR review, two are approved and ready, one came back with regulatory revisions. The brand manager comments on the regulatory revisions directly in the asset record, routes the updated draft back to the three reviewers, and queues the two approved pieces for the Tuesday send.

Field rep in a parking lot

Pre-call plan ready in 15 seconds offline.

A rep pulls into the parking lot for a 2 PM call on Dr. Chen, a cardiologist in Denver. The Strkr mobile app shows last visit, open commitments, consent scope, recent prescription data (if the territory has IQVIA sync enabled), and the three approved pieces matched to Dr. Chen's specialty. The rep walks in briefed and the post-call note takes 20 seconds including sample signature capture.

MSL unsolicited request

Scientific inquiry logged with the response packet attached.

A medical science liaison takes an unsolicited scientific inquiry from a thought leader at a university medical center. Strkr logs the inquiry, generates the response ticket for the medical information team, routes the standard response letter under medical approval, and attaches the delivered response packet to the HCP record. The documentation satisfies the unsolicited-request exception language under FDA guidance.

Speaker program Friday

Dinner program for 12 HCPs runs with cap math live.

The speaker events coordinator sets up a dinner program for 12 HCPs. Strkr calculates per-attendee meal cost against the applicable cap, checks each HCP's annual aggregate against the policy cap, flags one attendee who is approaching the cap and would need a different venue. The coordinator adjusts the venue and the program clears compliance in one review cycle instead of three.

Commercial analytics weekly

Market-share deltas plus call-activity correlation.

The commercial analytics team runs the weekly deck. Strkr dashboards pull call activity, sample distribution, speaker-program attendance, and overlay IQVIA prescription data at the territory level. The team identifies three territories where call cadence correlates with share gain and two where the correlation is thin, and the field leader gets specific coaching conversations instead of blanket cadence policy.

Compliance quarterly audit

OPDP inquiry answered in 20 minutes.

The compliance team gets an OPDP inquiry about the review and distribution history of a piece. The response in Strkr is a search by asset identifier that returns the MLR approvals, the campaigns the piece ran in, the HCPs who received it, the dates, the channel. The response packet is assembled in 20 minutes against a prior process that burned a week per inquiry.

Launch planning for new indication

Playbook cloned, timelines rebuilt, assets re-reviewed.

A new indication launch is 6 months out. The commercial team clones the Strkr launch playbook, adjusts timelines, pulls the asset list, routes the new indication-specific pieces through MLR, and sets up the Sunshine-tracking rules for the new product. The pre-launch sprint runs on an auditable timeline instead of a Confluence page nobody updated.

What this platform is not

The limits worth knowing before you buy.

A platform that will not tell you what it does not do is selling the demo. The cards below are where Strkr does not try to replace the specialty vendors a pharma commercial team already runs.

Not a Veeva CRM replacement

For top-20 pharma already standardized on Veeva, Strkr is complementary.

A top-20 pharma company that has standardized on Veeva CRM across global commercial organizations is not a Strkr replacement candidate for the Veeva stack. Strkr is the strong fit for mid-size commercial teams, specialty pharma, biotech pre-launch, and the digital-marketing surface that Veeva CRM does not cover natively.

Not a specialty MLR tool

Veeva Vault PromoMats is deeper on asset DAM.

Veeva Vault PromoMats carries deeper digital-asset management, long-form document controls, and multi-market syndication at the top-20 scale. Strkr MLR is strong for mid-size commercial teams and biotech pre-launch where the asset volume does not justify the Vault seat count.

Not a prescription-data provider

IQVIA and Symphony Health are the data layers.

Strkr ingests prescription data via API integration with IQVIA Xponent, Symphony Health, or similar market-data providers. Strkr does not sell the prescription data itself and does not try to replace the market-share analytics those providers specialize in.

Not a patient-support hub

TrialCard and Lash Group do the hub work.

Patient-support programs, copay card administration, and specialty-pharmacy coordination run on dedicated hub vendors. Strkr can integrate with hub data streams for program-performance reporting but does not try to replace the hub operational surface.

International regulatory nuance

EMA, PMDA, Health Canada rules out of scope for v1.

Strkr's regulated-marketing primitives are tuned for US pharma commercial today, with Health Canada considered in the roadmap for 2027. European EMA rules and Japanese PMDA rules require their own primitive set and are not promised in the current product. Teams with multinational commercial needs should scope accordingly.

Open API, not open to Zapier

First-class API integrations only.

Strkr integrates with specialty pharma systems through first-class API work rather than Zapier-style middleware. Veeva, IQVIA, Symphony, and the common hub vendors have direct integrations. Teams asking "will Zapier connect my Zoho Books to Strkr for Sunshine reporting" will get a native-integration conversation instead of a workflow-automation band-aid.

Head-to-head

Strkr vs typical pharma marketing stack.

The common comparison for mid-size pharma commercial teams is a Marketo plus Veeva Vault plus a bespoke MLR tool plus a Sunshine spreadsheet, versus Strkr running the commercial record end to end. Here is the head-to-head.

Feature Strkr Marketo + Vault + spreadsheet stack
MLR routing Built in, line-level comments, locked versions, campaign-gate enforcement Vault PromoMats (strong) plus email for mid-size teams without Vault
HCP consent model Structured per channel per specialty per scope, API-exposed Marketo opt-in bool plus a compliance spreadsheet
Sunshine Act capture First-class transfer-of-value object on HCP record, CMS fields built in Spreadsheet consolidation in Q1
Sample management PDMA signature capture on mobile, lot and expiry tracked Dedicated sample-management module or vendor
State-rule logic in Flow Conditioned on license state and specialty Rep training and manual compliance review
Audit retention 7 year field-level audit with user, timestamp, before, after Split across Marketo, Vault, and the finance spreadsheet
BAA and HIPAA BAA on every tenant that touches PHI Marketo and Vault sign BAAs; mid-tier vendors vary
Launch deployment time 3 to 6 weeks to pharma readiness 6 to 9 months on a full stack buildout
Pricing structure Flat per seat with commercial modules included Marketo plus Vault plus hub costs often exceed 150 dollars per seat per month
AI capability Strkr AI drafts call summaries, scientific inquiry responses, campaign copy on flat tier Marketo AI add-on with credit meter; Vault AI in pilot
How teams use Strkr

How pharma commercial teams run Strkr today.

The common thread across pharma teams running Strkr: the compliance primitives are built in rather than configured after purchase. The playbooks below are motions on live customer accounts in biotech and specialty pharma.

Specialty pharma, 45 reps

Pre-launch readiness in 5 weeks for a dermatology indication.

A specialty pharma team 6 months from launch stood up Strkr for commercial readiness in 5 weeks. The deployment covered 45 field reps across 8 territories, 2,400 target HCPs, MLR routing for 68 launch assets, speaker program setup, Sunshine Act capture, and IQVIA data integration. The alternative buildout quoted by two enterprise vendors was 8 months each, which would have put commercial infrastructure behind the launch date.

Clinical-stage biotech, 12-person commercial

First commercial record goes live 90 days before DDMAC letter.

A clinical-stage biotech preparing for first launch stood up Strkr with a 12-person commercial team 90 days before the expected DDMAC letter. The deployment covered KOL mapping (280 HCPs), MLR for 22 unbranded assets, consent capture flows, and the Sunshine infrastructure that would be live from day one of commercial activity. The biotech skipped the usual pre-launch spreadsheet-era and went live on structured records.

Mid-size pharma, 180 reps

OPDP inquiry answered in 22 minutes with the full response packet.

A mid-size pharma commercial team received an OPDP inquiry about the distribution history of an approved piece. In Strkr the response was a filter by asset ID returning the MLR approval chain, the three campaigns the piece ran in, the 1,840 HCPs who received it, the channels, the dates. The response packet assembled in 22 minutes against a prior process that burned a week.

Rare-disease biotech, 8 reps

Patient-advocacy outreach captured with the right consent scope.

A rare-disease biotech runs patient-advocacy outreach alongside the HCP motion. Strkr handles both record types with separate consent models (patient consent scoped to patient-support eligibility, HCP consent scoped to clinical education). The 8-rep field team covers 320 HCPs and 180 patient advocates with a single tenant, which simplified the compliance review surface the general counsel oversees.

Oncology biotech, 60 field + MSL

MSL scientific-inquiry workflow pays off in SRC audit.

An oncology biotech runs 24 MSLs alongside 36 field reps. Scientific inquiries route through Strkr with the response packet, approval chain, and delivered documentation attached to the HCP record. The internal scientific review committee quarterly audit pulled 40 inquiries at random and found zero process gaps across the full year, which was a first for the team coming off a Veeva-plus-SharePoint hybrid flow.

Pharma commercial infrastructure that stands up to an OPDP inquiry.

See how Strkr runs MLR review, HCP consent, Sunshine Act capture, PDMA sample management, and speaker-program tracking inside one tenant. Deployment to pharma readiness in 3 to 6 weeks on a flat per-seat line.

Common questions

What buyers in this bucket ask most.

Is Strkr HIPAA compliant and will you sign a BAA for a pharma commercial tenant?

Yes. Strkr is HIPAA compliant and signs a Business Associate Agreement for every tenant that handles protected health information. The BAA covers encryption in transit and at rest, access logging, breach notification procedures, and the admin training materials that cover tenant management. For pharma commercial, PHI exposure usually enters through patient-support programs and copay cards; the BAA applies to the full tenant so the compliance posture is uniform.

How does Strkr handle MLR review and prevent an unapproved asset from going out?

MLR review runs inside the asset record with routed approvals to medical, legal, and regulatory reviewers. Each reviewer leaves line-level comments on the draft; required-approval gates mean the asset cannot move to Approved state until all three sign off. The campaign-send layer enforces a hard gate: an asset not in Approved state cannot be attached to a campaign send. The gate is structural rather than policy, so a well-meaning marketer cannot route around it.

Can Strkr handle Sunshine Act transfer-of-value reporting end to end?

Yes. The HCP record carries structured transfer-of-value fields matching the CMS Open Payments schema: date, amount, nature of payment, form of payment, product indication, physician NPI, physician license state, teaching-hospital flag. Field reps capture meals and samples through the mobile app. Speaker programs roll up to the HCP automatically. The annual CMS filing is a report run against this structured dataset, with reconciliation against the finance-side ledger built in.

What about state-level HCP interaction rules like Vermont, Minnesota, Massachusetts?

Each state with HCP-interaction rules carries its own license lookup and local rules. The Flow canvas can condition on HCP license state, specialty, consent scope, and the local gift ceiling where applicable. A field rep triggering a sample-delivery flow in Vermont gets Vermont logic; the same flow for a Texas prescriber gets Texas logic. The branching is explicit and auditable rather than reliant on rep training.

Does Strkr replace Veeva CRM for pharma commercial?

For top-20 pharma already standardized on Veeva across global commercial, no; Strkr complements the Veeva stack and plays strongest on the mid-size commercial and biotech pre-launch segments. For mid-size commercial teams, specialty pharma, and clinical-stage biotech preparing for first launch, Strkr is a complete replacement for the Marketo plus Vault plus spreadsheet stack that is the common alternative. The deployment time is weeks rather than quarters.

What is the pricing structure for a pharma commercial deployment?

Strkr is flat per seat with the commercial modules (MLR, Sunshine capture, consent management, speaker program tracking, PDMA sample management) included on paid tiers. There is no credit meter on Strkr AI, which drafts call summaries, campaign copy, and scientific-inquiry response letters on the flat line. For a 45-rep field team the all-in bill lands well under a Marketo plus Vault stack at equivalent seat count, with the specialty-pharma primitives built in rather than configured per customer.

Try it free. Bring your team next week.

No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.